Clindamycin Injection, Solution
Product Images NDC 71872-7191

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 71872-7191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7191-1.pdp (71872 7191 1)

Label for Clindamycin Injection, USP 150 mg/mL solution in a 2 mL single-dose vial, containing 300 mg per vial. Intended for intramuscular or intravenous use, sterile and nonpyrogenic. Manufactured for Sagent Pharmaceuticals and repackaged by Medical Purchasing Solutions, Scottsdale, AZ.*

FDA Label Image

Structural Formula (Cli04 0015 01)

Chemical structure of clindamycin phosphate, displaying the molecular arrangement of its atoms and bonds as typically used to represent the active pharmaceutical ingredient in this injection solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.